Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.
Business Model:
Revenue: $0
Employees: 0-0
Address: 45 Falkirk Lane
City: Hillsborough
State: CA
Zip: 94010
Country: US
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases. The company’s first target indication is chronic Hepatitis B, which remains a worldwide prevalent disease with urgent unmet medical need. Bluejay is advancing two innovative approaches with the potential for high rate of functional cure: best-in-class fully human IgG1 anti-HBs monoclonal antibodies and first-in-class HBsAg oral small molecule inhibitors. The company believes that by reducing hepatitis B surface antigen and restoring adaptive immunity a functional cure could be achieved for patients.
Contact Phone:
+16502185487
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2022 | Series B | $41M |
Arkin Bio Ventures RiverVest Venture Partners Yonjin Capital Octagon Capital Synergenics LLC |
8/2022 | Series B | $0 |
Arkin Bio Ventures Octagon Capital Advisors RiverVest Synergenics Yonjin Venture Arkin Bio Ventures Octagon Capital Advisors RiverVest Synergenics Yonjin Venture |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|